CooperSurgical has contributed over 300 cord blood samples to advance stem cell research at the University of Toronto. The company also provided more funding for the project. Dr Ian Rogers is spearheading the stem cell research. Thus his team gains access to valuable biological resources.
The donation is from the Victoria Angel Registry of Hope (VAR) This non-profit charitable public cord blood bank was a division of CooperSurgical’s Cells for Life. VAR also pointed out the collection and preservation of cord blood units donated by the public. The units could be used by doctors and scientists for medical treatment and research.
Now, CooperSurgical is transferring these resources along with financial support. Consequently, the company helps ensure that this important legacy continues. In turn, the scientific and medical communities will keep benefiting from it.
Holly Sheffield, President of CooperSurgical, explained the company’s motivation behind the donation.
“Through this donation, we are proud to extend the impact of the Victoria Angel Registry of Hope and support critical research that has the potential to transform patient care,” said Holly Sheffield, President of CooperSurgical. “Guided by our mission of accelerating what’s possible for women, babies, and families, CooperSurgical remains committed to advancing innovation and helping improve outcomes through meaningful collaboration.”
Dr. Ian Rogers to Advance Regenerative Medicine Research
Dr. Rogers is a top researcher in stem cell biology. He’ll be responsible for integrating and using these cord blood units. So his team will use them to further research in regenerative medicine and new therapeutic approaches. Experts say this work should give novel insights into the potential of stem cells. It may also help to drive next-generation treatments and transform the care that patients receive.
Dr. Rogers also welcomed the donation and highlighted its importance for future research.
“This donation represents an important step forward in advancing stem cell research and its clinical potential. Access to high-quality cord blood units is essential to supporting the scientific work that will shape the next future therapies,” said Dr. Rogers. “We are grateful to CooperSurgical for enabling continued research that may lead to new treatments and improved patient outcomes.”
Why Cord Blood Matters for Medical Research
Cord blood is rich in stem cells. They can differentiate into various types of blood and immune cells. For this reason, cord blood is an important resource for research on many different diseases and medical conditions. These include regenerative therapies, blood disorders, and immune deficiencies.
CooperSurgical continues to break new ground in science with initiatives like this. The company also reaffirms its commitment to improving health outcomes around the world. In general, the donation helps to strengthen the links between industry support and academic research.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
